相关实验视频
Updated: May 10, 2025
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.4K
对女性的终端心力衰竭护理:更好还是更多的相同?
Vithoosharan Sivanathan1, Natasha Smallwood2,3, Dominica Zentner1,4
1Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Internal medicine journal
|April 28, 2025
概括
患有慢性心力衰竭 (CHF) 的女性接受了更多的终身症状管理和息治疗. 然而,他们不太可能在死亡之前接受维持生命的干预措施或访问门诊慢性病计划.
科学领域:
- 心脏病学 心脏病学
- 抚慰性护理是一种缓解性护理.
- 老年病的医生 老年病的医生
背景情况:
- 患有慢性心力衰竭 (CHF) 的女性面临着显著的症状负担,活动障碍和虚弱.
- 息治疗可以改善心血管疾病患者的生活质量,但及时获得治疗仍然是一个挑战.
研究的目的:
- 调查澳大利亚慢性心力衰竭终端住院期间的专家息护理转诊和提供息护理要素的性别差异.
主要方法:
- 对2011年7月至2019年12月期间所有导致死亡的慢性心力衰竭入院病例的医疗记录的回顾性审查.
- 分析患者人口统计,息护理转诊,干预和先前的医疗保健利用情况.
主要成果:
- 在男性和女性 (P = 0.80) 之间的住院专家息护理转诊率没有显著差异.
- 妇女接受维持生命干预的可能性较低 (OR = 1.71,P = 0.04),但更有可能接受终端症状管理 (OR = 3.19,P = 0.01) 和息方法 (OR = 1.68,P < 0.01).
- 在死亡前的12个月里,妇女的急诊室呈现率较低 (OR = 0.50,P = 0.04) 和门诊慢性病计划转诊率较低 (OR = 0.58,P = 0.04).
结论:
- 这项研究揭示了慢性心力衰竭患者生命末期护理中的有趣的基于性别的差异.
- 虽然女性接受了更多以症状为重点的息治疗,但她们不太可能接受积极的维持生命的治疗.
- 需要进一步的研究来了解这些差异,特别是考虑到女性心脏护理及时性的已知差异.
相关概念视频
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
01:22Heart Failure Drugs: β-Blockers
259
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
259
01:22Heart Failure Drugs: Diuretics
277
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
277
01:26Heart Failure Drugs: Inotropic Agents
401
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
401
01:23Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K